Clinical Trials Directory

Trials / Completed

CompletedNCT01359930

Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study

Phase 1 Study of Interactions Between Oral Naltrexone and Bupropion and Intravenous Methamphetamine in Methamphetamine Experienced Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
16 (estimated)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
21 Years – 50 Years
Healthy volunteers
Accepted

Summary

The study is to primarily measure safety and interactions between oral doses of Naltrexone/Bupropion and i.v. Methamphetamine.

Conditions

Interventions

TypeNameDescription
OTHERplacebomatching placebo
DRUGNaltrexone and Bupropion SR25mg bid/day (NX) 200mg bid/day (BUP)

Timeline

Start date
2011-08-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2011-05-25
Last updated
2017-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01359930. Inclusion in this directory is not an endorsement.

Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study (NCT01359930) · Clinical Trials Directory